<code id='AA4D59F6E8'></code><style id='AA4D59F6E8'></style>
    • <acronym id='AA4D59F6E8'></acronym>
      <center id='AA4D59F6E8'><center id='AA4D59F6E8'><tfoot id='AA4D59F6E8'></tfoot></center><abbr id='AA4D59F6E8'><dir id='AA4D59F6E8'><tfoot id='AA4D59F6E8'></tfoot><noframes id='AA4D59F6E8'>

    • <optgroup id='AA4D59F6E8'><strike id='AA4D59F6E8'><sup id='AA4D59F6E8'></sup></strike><code id='AA4D59F6E8'></code></optgroup>
        1. <b id='AA4D59F6E8'><label id='AA4D59F6E8'><select id='AA4D59F6E8'><dt id='AA4D59F6E8'><span id='AA4D59F6E8'></span></dt></select></label></b><u id='AA4D59F6E8'></u>
          <i id='AA4D59F6E8'><strike id='AA4D59F6E8'><tt id='AA4D59F6E8'><pre id='AA4D59F6E8'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:78526
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          BMS, looking to build heart drug business, turns to AI for diagnosis
          BMS, looking to build heart drug business, turns to AI for diagnosis

          AdobeAsBristolMyersSquibbworkstobuilditstreatmentforaheartconditionthatcancausedifficultybreathingin

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          For Cytokinetics, FDA rejection of heart drug would help, not hinder

          MollyFerguson/STATCytokineticswasfounded26yearsagobuthasnotyetdevelopedadrugsuccessfullytoapproval.T